These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 887420)
1. [Immune deficiences during pyoderma gangrenosum associated with a polycythemia vera]. Deschamps P; Leroy D; Dresch C; Michel M Nouv Presse Med; 1977 Jun; 6(26):2339-41. PubMed ID: 887420 [TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum with myelofibrosis. Gopinath DK; Wolfe RD; Sabharwal K J Ky Med Assoc; 1974 Oct; 72(10):548-50, 566. PubMed ID: 4443631 [No Abstract] [Full Text] [Related]
3. In vitro studies on microphage functions in chronic pyoderma vegetans. Djawari D; Hornstein OP Arch Dermatol Res; 1978; 263(1):97-104. PubMed ID: 394690 [TBL] [Abstract][Full Text] [Related]
4. Tissue antigens and cytotoxic antibodies in polycythaemia rubra vera. Nagy G; Stenszky V; Murvay K Haematologia (Budap); 1975; 9(3-4):279-82. PubMed ID: 1230410 [TBL] [Abstract][Full Text] [Related]
5. Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemia. Ho KK; Otridge BW; Vandenberg E; Powell FC J Am Acad Dermatol; 1992 Nov; 27(5 Pt 2):804-8. PubMed ID: 1469131 [TBL] [Abstract][Full Text] [Related]
6. Pyoderma gangrenosum with altered cellular immunity and dermonecrotic factor. Delescluse J; De Bast C; Achten G Br J Dermatol; 1972 Dec; 87(6):529-32. PubMed ID: 4567639 [No Abstract] [Full Text] [Related]
9. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity. Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837 [TBL] [Abstract][Full Text] [Related]
13. Polycythemia vera in childhood. A case with chromosomal abnormality, immunoglobulin deficiency, and chronic consumption coagulopathy. Natelson EA; Lynch EC; Britton HA; Alfrey CP Am J Dis Child; 1971 Sep; 122(3):241-4. PubMed ID: 5568588 [No Abstract] [Full Text] [Related]
14. Present status of pyoderma gangrenosum. Review of 21 cases. Prystowsky JH; Kahn SN; Lazarus GS Arch Dermatol; 1989 Jan; 125(1):57-64. PubMed ID: 2642682 [TBL] [Abstract][Full Text] [Related]
15. Iron metabolism in polycythaemia rubra vera and secondary polycythaemia. Nagy G; Dezsö I; Varsányi M Haematologia (Budap); 1975; 9(1-2):79-84. PubMed ID: 1230402 [TBL] [Abstract][Full Text] [Related]
16. [Buccal and ocular localizations of pyoderma gangrenosum in Vaquez's disease]. Bertram-Callens A; Machet L; Vaillant L; Camenen I; Lorette G Ann Dermatol Venereol; 1991; 118(9):611-4. PubMed ID: 1759750 [No Abstract] [Full Text] [Related]
17. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Holt PJ; Davies MG; Saunders KC; Nuki G Medicine (Baltimore); 1980 Mar; 59(2):114-33. PubMed ID: 7360040 [TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum with cellular immunity defect and red cell aplasia. Clayton R Proc R Soc Med; 1977 Aug; 70(8):571-2. PubMed ID: 303364 [No Abstract] [Full Text] [Related]
19. [The combined therapy of chronic pyoderma taking into account body immunological reactivity and staphylococcal antibiotic resistance]. Rodionov AN; Khavinson VKh; Barbinov VV Voen Med Zh; 1992 Aug; (8):28-30. PubMed ID: 1441267 [TBL] [Abstract][Full Text] [Related]
20. [Onset of polycythemia in idiopathic myelofibrosis. Description of a clinical case and review of the literature]. Pagano L; Teofili L; Marra R; Storti S; Rabbitti C; Leone G; Bizzi B Minerva Med; 1988 Jan; 79(1):51-4. PubMed ID: 3277085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]